ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 11 filers reported holding ADIAL PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $37,499 | -51.8% | 180,285 | -18.9% | 0.00% | – |
Q1 2023 | $77,799 | +301.4% | 222,283 | +144.3% | 0.00% | – |
Q4 2022 | $19,382 | -85.4% | 90,996 | -8.2% | 0.00% | – |
Q2 2022 | $133,000 | +269.4% | 99,103 | +447.0% | 0.00% | – |
Q1 2022 | $36,000 | -85.1% | 18,117 | -79.8% | 0.00% | – |
Q4 2021 | $242,000 | +8.0% | 89,784 | +72.0% | 0.00% | – |
Q3 2021 | $224,000 | +1144.4% | 52,200 | +280.6% | 0.00% | – |
Q1 2020 | $18,000 | – | 13,714 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 1,817,454 | $3,653,000 | 0.07% |
CSS LLC/IL | 41,300 | $83,000 | 0.00% |
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 35,000 | $70,000 | 0.00% |
CSS LLC/IL | 33,900 | $68,000 | 0.00% |
Private Advisor Group, LLC | 34,150 | $69,000 | 0.00% |
OPPENHEIMER & CO INC | 38,500 | $77,000 | 0.00% |
High Net Worth Advisory Group LLC | 1,000 | $2,000 | 0.00% |
VANGUARD GROUP INC | 590,852 | $1,187,000 | 0.00% |
UBS Group AG | 6,840 | $14,000 | 0.00% |
OSAIC HOLDINGS, INC. | 8,321 | $25,000 | 0.00% |